相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents
Kyogo Suzuki et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Non-Hodgkin Lymphoma: Diagnosis and Treatment
Stephen M. Ansell
MAYO CLINIC PROCEEDINGS (2015)
The Genetic Landscape of Diffuse Large B-Cell Lymphoma
Laura Pasqualucci et al.
SEMINARS IN HEMATOLOGY (2015)
Class IIa HDACs - new insights into their functions in physiology and pathology
Maribel Parra
FEBS JOURNAL (2015)
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
Natalie S. Grover et al.
PHARMACEUTICALS (2015)
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis
Tobias Berg et al.
BLOOD (2014)
HDAC9 Knockout Mice Are Protected From Adipose Tissue Dysfunction and Systemic Metabolic Disease During High-Fat Feeding
Tapan K. Chatterjee et al.
DIABETES (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells
Kadir C. Akdemir et al.
NUCLEIC ACIDS RESEARCH (2014)
Current clinical trials with polo-like kinase 1 inhibitors in solid tumors
Hyungshin Yim
ANTI-CANCER DRUGS (2013)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
Diffuse large B-cell lymphoma
Maurizio Martelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies
Lindsey N. Micel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma
Carol Y. Ying et al.
NATURE IMMUNOLOGY (2013)
Structural basis for the inhibition of Polo-like kinase 1
Jun Xu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Andrea Franceschini et al.
NUCLEIC ACIDS RESEARCH (2013)
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
Melanie R. Hassler et al.
EPIGENOMICS (2013)
Romidepsin for Cutaneous T-cell Lymphoma
H. Miles Prince et al.
CLINICAL CANCER RESEARCH (2012)
Roles of BCL6 in normal and transformed germinal center B cells
Katia Basso et al.
IMMUNOLOGICAL REVIEWS (2012)
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke
Celine Bellenguez et al.
NATURE GENETICS (2012)
Exon 1 Disruption Alters Tissue-Specific Expression of Mouse p53 and Results in Selective Development of B Cell Lymphomas
Y. Jeffrey Chiang et al.
PLOS ONE (2012)
Histone Deacetylases 6 and 9 and Sirtuin-1 Control Foxp3+ Regulatory T Cell Function Through Shared and Isoform-Specific Mechanisms
Ulf H. Beier et al.
SCIENCE SIGNALING (2012)
Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia
Jenny Y. Sun et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Histone Deacetylase 9 Deficiency Protects against Effector T Cell-mediated Systemic Autoimmunity
Kailin Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program
Michael R. Green et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anticancer therapy with checkpoint inhibitors: what, where and when?
Michelle D. Garrett et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells
Katia Basso et al.
BLOOD (2010)
Guidelines for the welfare and use of animals in cancer research
P. Workman et al.
BRITISH JOURNAL OF CANCER (2010)
Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
Daniel Antunes Moreno et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma
Jonathan Mandelbaum et al.
CANCER CELL (2010)
HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
Till Milde et al.
CLINICAL CANCER RESEARCH (2010)
Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice
Edwin F. de Zoeten et al.
GASTROENTEROLOGY (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Reference alignment of SNP microarray signals for copy number analysis of tumors
Stan Pounds et al.
BIOINFORMATICS (2009)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Class IIa histone deacetylases: conducting development and differentiation
Maud Martin et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2009)
Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-Cell lymphoma
Ji Eun Kim et al.
MODERN PATHOLOGY (2009)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Fast Gene Ontology based clustering for microarray experiments
Kristian Ovaska et al.
BioData Mining (2009)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Xiang-Jiao Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
Expression of PLK1 and survivin in diffuse large B- cell lymphoma
Lin Liu et al.
LEUKEMIA & LYMPHOMA (2007)
Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation
Michael Haberland et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Localization of retinaldehyde dehydrogenases and retinoid binding proteins to sustentacular cells, glia, Bowman's gland cells, and stroma: Potential sites of retinoic acid synthesis in the postnatal rat olfactory organ
MA Asson-Batres et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma
O Margalit et al.
BLOOD (2006)
A global map of p53 transcription-factor binding sites in the human genome
CL Wei et al.
CELL (2006)
Analysis of BCL6-interacting proteins by tandem mass spectrometry
RR Miles et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
S Bea et al.
BLOOD (2005)
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma
H Tagawa et al.
BLOOD (2005)
Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome
F Rubio-Moscardo et al.
BLOOD (2005)
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice
G Cattoretti et al.
CANCER CELL (2005)
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
RT Phan et al.
NATURE (2004)
Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation
K Ando et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The KEGG resource for deciphering the genome
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2004)
Polo-like kinases and the orchestration of cell division
FA Barr et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
The histone deacetylase 9 gene encodes multiple protein isoforms
K Petrie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Transcriptional analysis of the B cell germinal center reaction
U Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor
C Lemercier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Progression to large B-cell lymphoma in splenic marginal zone lymphoma -: A description of a series of 12 cases
FI Camacho et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)